Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment
|更新时间:2024-07-12
|
Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment
“The latest research shows that Zhengqingfeng Tongning tablets can effectively reduce immune inflammatory indicators and improve quality of life in patients with rheumatoid arthritis, which is comparable to the efficacy of methotrexate. Combined use may become a new option for treating active rheumatoid arthritis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 16, Pages: 132-139(2024)
CHEN Junjie,SUN Yue,LI Ming,et al.Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):132-139.
CHEN Junjie,SUN Yue,LI Ming,et al.Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(16):132-139. DOI: 10.13422/j.cnki.syfjx.20242091.
Multicenter Clinical Efficacy of Zhengqing Fengtongning Tablets in Treating Rheumatoid Arthritis Patients with Syndrome of Wind-cold-dampness Impediment
Editorial Explanation of Guidelines for Establishing Animal Models of Rheumatoid Arthritis with Cold-dampness Obstruction Syndrome and Dampness-heat Obstruction Syndrome
Guidelines for Establishing Animal Models of Rheumatoid Arthritis with Cold-dampness Obstruction Syndrome and Dampness-heat Obstruction Syndrome
Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome
Pathogenesis and Traditional Chinese Medicine Treatment of Rheumatoid Arthritis Based on Theory of "Harmful Hyperactivity and Responding Inhibition"
Related Author
LIN Na
ZHANG Yanqiong
XIAO Changhong
XU Shijun
MAO Xia
Representation Preparation Group
TU Shenghao
SUN Jianning
Related Institution
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Southern Medical University Hospital of Integrated Chinese and Western Medicine
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
School of Chinese Materia Medica, Beijing University of Chinese Medicine
School of Pharmacy,Chengdu University of Traditional Chinese Medicine